While neurotechnology holds great promise for enhancing human capabilities and addressing various health challenges, it also necessitates careful consideration of the associated risks and ethical dilemmas. The rapid advancement in brain-computer interfaces, for instance, raises questions about privacy and informed consent in accessing neural data.
How can we ensure their responsible development, integration, and deployment to unlock new avenues for human enhancement, medical treatment, communication, and cognitive augmentation?

Robinson O. Everett Professor of Law and Philosophy; Director, Duke Science and Society, Duke University

Founder and Chief Executive Officer, Synchron

Centre for Health and Healthcare, World Economic Forum
Brain–computer interfaces are beginning to move from research into early medical use. What benefits are realistic for health, and where should societies set limits to protect autonomy?
Watch the session featured at the Annual Meeting 2026, led by Michael Mager (Co-Founder and CEO of Precision Neuroscience) and Irene Tracey (Vice-Chancellor of the University of Oxford).
A new generation of neurotechnology could help billions of people, so what’s its real potential, and what are the pitfalls? On the latest #RadioDavos we speak to Jen French, who had a neurotech implant after a snowboard accident made her quadriplegic, and knows the benefits and drawbacks. And Tom Oxley, founder of startup Synchron explains the rise of ‘brain computer interfaces’
Applying technology to neurological conditions could represent a paradigm shift with the potential to transform treatment, restore independence and redefine the possibilities for millions living with neurological impairments.
The network convenes over 700 experts from academia, business, government, civil society and international organizations, operating as a time-bound think-tank, grouped in expertise-based thematic councils, to identify and disseminate transformative ideas with the potential for positive global impact.